Item 5. Other Information
Item 5. Other Information
See the section entitled “Compliance with Nasdaq Listing Standards” in Item 2 of Part I of this Quarterly
Report on Form 10-Q for details regarding our noncompliance with the Nasdaq listing rules.
Item 6. Exhibits
The following exhibits are filed herewith or are incorporated
by reference to exhibits previously filed with the SEC.
Exhibit No.
31.1*
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002
31.2*
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002
32.1*
Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002
32.2*
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101.INS*
Inline XBRL Instance Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
*
Filed herewith.
29
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
BIOFRONTERA INC.
Date: May 15, 2025
By:
/s/ Hermann Luebbert
Name:
Hermann Luebbert
Title:
Chief Executive Officer & Chairman
( Principal Executive Officer)
Date: May 15, 2025
By:
/s/ E. Fred Leffler III
Name:
E. Fred Leffler, III
Title:
Chief Financial Officer
(Principal Financial Officer)
30
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.